Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Cash (2016 - 2025)

Historic Change in Cash for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$293000.0.

  • Icu Medical's Change in Cash fell 10297.04% to -$293000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.8 million, marking a year-over-year decrease of 11108.22%. This contributed to the annual value of $54.3 million for FY2024, which is 1960.03% up from last year.
  • Per Icu Medical's latest filing, its Change in Cash stood at -$293000.0 for Q3 2025, which was down 10297.04% from $10.3 million recorded in Q2 2025.
  • Icu Medical's Change in Cash's 5-year high stood at $57.4 million during Q3 2021, with a 5-year trough of -$223.4 million in Q1 2022.
  • Moreover, its 5-year median value for Change in Cash was $1.3 million (2023), whereas its average is -$5.1 million.
  • As far as peak fluctuations go, Icu Medical's Change in Cash plummeted by 89354.58% in 2022, and later soared by 65586.21% in 2024.
  • Over the past 5 years, Icu Medical's Change in Cash (Quarter) stood at $33.3 million in 2021, then crashed by 205.26% to -$35.1 million in 2022, then soared by 262.5% to $57.0 million in 2023, then plummeted by 106.92% to -$3.9 million in 2024, then skyrocketed by 92.57% to -$293000.0 in 2025.
  • Its Change in Cash stands at -$293000.0 for Q3 2025, versus $10.3 million for Q2 2025 and -$18.9 million for Q1 2025.